80 mg tirzepatide FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly GLP-1 prescribing stabilizes, tirzepatide leads:

Always seek professional advice from a healthcare provider before proceeding

Patients who consumed two or more alcoholic drinks per week within 12 hours of peptide dosing reported 40% lower subjective recovery improvements and 30% smaller reductions in body fat percentage over 90 days compared to abstinent users

These findings position retatrutide as a leading investigational peptide for obesity, type 2 diabetes, metabolic dysfunction-associated steatotic liver disease (MASLD), and related metabolic disorders

Cons: 250mg is a quarter of the 1000mg trial arm

The window of highest oral-drug-absorption risk is comparable for both agents